Yi Ma

State Key Laboratory Of Natural Medicines
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Design, Synthesis, and Evaluation of a Novel-Labeled Small Molecule Inhibitor-Based PET/SPECT Tracer Targeting HSP90.

Design, Synthesis, and Evaluation of a Novel-Labeled Small Molecule Inhibitor-Based PET/SPECT Tracer Targeting HSP90.

Journal: Journal of medicinal chemistry
Published: May 04, 2026

Crystal Facet-Polysaccharide Matching in CFS-P Nanocrystals Drives Fungal Uptake, Vacuole Destruction, and Selective Antifungal Activity.

Crystal Facet-Polysaccharide Matching in CFS-P Nanocrystals Drives Fungal Uptake, Vacuole Destruction, and Selective Antifungal Activity.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 03, 2025

Ultraviolet-tyrosinase cascade caged antisense oligonucleotide for precise treatment of hyperpigmentation.

Ultraviolet-tyrosinase cascade caged antisense oligonucleotide for precise treatment of hyperpigmentation.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 20, 2025

Innovative DNA tetrahedron inspired by ancient mortise-and-tenon technique offers new immunotherapy strategy for metastatic breast cancer.

Innovative DNA tetrahedron inspired by ancient mortise-and-tenon technique offers new immunotherapy strategy for metastatic breast cancer.

Journal: Biomaterials
Published: January 13, 2025

Discovery of Natural Resorcylic Acid Lactones as Novel Potent Copper Ionophores Covalently Targeting PRDX1 to Induce Cuproptosis for Triple-Negative Breast Cancer Therapy.

Discovery of Natural Resorcylic Acid Lactones as Novel Potent Copper Ionophores Covalently Targeting PRDX1 to Induce Cuproptosis for Triple-Negative Breast Cancer Therapy.

Journal: ACS central science
Published: December 22, 2024

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

Journal: Nature communications
Published: July 24, 2024

Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small-Molecule Inhibitors Regulating Metabolic Reprogramming.

Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small-Molecule Inhibitors Regulating Metabolic Reprogramming.

Journal: Angewandte Chemie (International ed. in English)
Published: February 04, 2024

Increasing the tumour targeting of antitumour drugs through anlotinib-mediated modulation of the extracellular matrix and the RhoA/ROCK signalling pathway.

Increasing the tumour targeting of antitumour drugs through anlotinib-mediated modulation of the extracellular matrix and the RhoA/ROCK signalling pathway.

Journal: Journal of pharmaceutical analysis
Published: November 11, 2023

"Closed-Loop" O2-Economizer Induced In Situ Therapeutic Vaccine against Hypoxic Tumors.

"Closed-Loop" O2-Economizer Induced In Situ Therapeutic Vaccine against Hypoxic Tumors.

Journal: ACS nano
Published: October 25, 2023

Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer.

Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer.

Journal: Acta pharmaceutica Sinica. B
Published: June 29, 2023

DNA framework-engineered chimeras platform enables selectively targeted protein degradation.

DNA framework-engineered chimeras platform enables selectively targeted protein degradation.

Journal: Nature communications
Published: January 17, 2023

Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents.

Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents.

Journal: Journal of medicinal chemistry
Published: September 07, 2022
Showing 1-12 of 26

Last Updated: 09/26/2026